About Medrio
Medrio is a company based in San Francisco (United States) founded in 2005. Medrio has raised $32.03 million across 2 funding rounds from investors including Questa Capital and Ulu Ventures. The company has 120 employees as of December 31, 2022. Medrio has completed 1 acquisition, including HMD clinical. Medrio offers products and services including CDMS/EDC, eCOA/ePRO, eConsent, and RTSM. Medrio operates in a competitive market with competitors including L7 Informatics, MDClone, Clinical Research IO, VivoSense and Castor, among others.
- Headquarter San Francisco, United States
- Employees 120 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medrio
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$32.03 M (USD)
in 2 rounds
-
Latest Funding Round
$30 M (USD), Series B
May 26, 2017
-
Investors
Questa Capital
& 1 more
-
Employee Count
120
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medrio
Medrio offers a comprehensive portfolio of products and services, including CDMS/EDC, eCOA/ePRO, eConsent, and RTSM.
Platform for electronic data collection in clinical trials.
Tools for capturing clinical outcome assessments remotely.
System for electronic participant consent processes.
Software for trial supply randomization and control.
People of Medrio
Unlock access to complete
Unlock access to complete
Sales and Marketing
20 people
Software Development Team
8 people
Data Analysis and Operations Team
7 people
Leadership Team
6 people
Product Management Team
3 people
Human Resources and Administration
3 people
Finance and Accounting
3 people
Strategic Team
2 people
Unlock access to complete
Funding Insights of Medrio
Medrio has successfully raised a total of $32.03M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medrio
Medrio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Questa Capital and Ulu Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage VC and PE investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Seed-stage funding is provided to innovative founder teams.
|
Locked | Locked | Locked |
Investor details for Medrio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medrio
Medrio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HMD clinical.
Investment portfolio details for Medrio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical Trial Management System
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for Medrio
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Medrio
Detailed financials for Medrio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medrio Comparisons
Peer comparison for Medrio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medrio
Medrio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as L7 Informatics, MDClone, Clinical Research IO, VivoSense and Castor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical trial workflow management software is provided for laboratories.
|
|
| Locked | Locked | Locked |
Provider of software that creates synthetic medical records for fictitious patients
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for research sites.
|
|
| Locked | Locked | Locked |
Wearable sensor research analysis platform
|
|
| Locked | Locked | Locked |
Electronic data capture platforms for medical research are offered.
|
Detailed competitors of Medrio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medrio
Complete news archive for Medrio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medrio
Medrio was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Medrio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Nicole DuPont Latimer is the current CEO of Medrio.
Medrio is a funded company, having raised a total of $32.03M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Medrio is 120.
Medrio was founded in 2005 in San Francisco, United States, and operates in the clinical trials sector. An integrated eClinical Software as a Service (SaaS) platform is offered, featuring a fully hosted Electronic Data Capture (EDC) system. Studies are enabled to be built entirely online without custom development requirements. Control is placed in the hands of study managers, by which study timelines and costs are reduced.
Medrio's top competitors include L7 Informatics, MDClone and Clinical Research IO.
Medrio offers CDMS/EDC, eCOA/ePRO, eConsent, and RTSM.
Medrio has made 1 acquisition, including HMD clinical.
Medrio has 2 investors. Key investors include Questa Capital, and Ulu Ventures.